HOME >> MEDICINE >> NEWS
Highly active antiretrovirals for HIV can substantially reduce rates of AIDS

Highly active antiretroviral therapy (HAART) for HIV-infected individuals could reduce the rate of progression to AIDS or death by 86% when compared with no treatment, concludes an article in this week's issue of THE LANCET.

HAART is a combination of at least three antiretroviral drugs from at least two drug classes. Randomised trials of its effectiveness have only followed-up patients for a year or less. The effectiveness of HAART over several years has therefore been unknown until now.

Jonathan Sterne (University of Bristol, UK) and colleagues studied over 3,200 patients from the Swiss HIV Cohort Study who had HIV but were free of AIDS when recruited to the study. Patients were included in the latest analysis if they had been examined after January 1996, when HAART became available in Switzerland. A total of 400 patients subsequently progressed to AIDS or died. The investigators compared HAART with no treatment in 2,161 patients and HAART with dual therapy (formerly the best treatment option) in 1,276 patients. The analysis used new statistical methods that account for the fact that patients tend to be treated when HIV depletes their immune system, and tend to remain untreated if their immune system is relatively intact. The researchers found that HAART's effectiveness compared with no treatment increased with time since initiation, and that HAART was less beneficial for patients who were presumed to have contracted HIV via intravenous drug use than for other patients.

Dr Sterne states: "Our results indicate that HAART reduced the rate of progression to AIDS by 86%, and that its effectiveness compared with no treatment increased with time since initiation. These dramatic benefits provide a context for concerns about possible adverse effects of HAART. The very large benefits of HAART that are achievable in developed countries should remind us of the urgency of providing treatment for the millions of people who could benefit in other parts of
'"/>

Contact: Joe Santangelo
j.santangelo@elsevier.com
1-212-633-3810
Lancet
28-Jul-2005


Page: 1 2

Related medicine news :

1. Inactive kids storing up illness for the future
2. Pro-vitamin E shown to be active against breast cancer cells
3. Adolescent girls more active if neighborhoods have parks
4. Ear infection expert from Childrens Hospital of Pittsburgh leads interactive demo on diagnosis
5. Synthetic version of scorpion venom delivers radioactive iodine to malignant brain tumors
6. Slowing Alzheimers disease by keeping mind and body active
7. Randomized trial in Zimbabwe suggests how to make HIV testing and counselling attractive
8. Johns Hopkins lab scientists tame overactive CF protein
9. Radioactive scorpion venom for fighting cancer
10. New study reveals Tocilizumab in monotherapy significantly improves signs and symptoms of active RA
11. New results from the landmark PROactive trial

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/3/2020)... ... 03, 2020 , ... BluePearl Specialty and Emergency Pet ... (AFSP) annual signature event, Out of the Darkness (OOTD), which unites more than ... awareness of suicide prevention. To ensure Associate safety, BluePearl will not be participating ...
(Date:9/3/2020)... (PRWEB) , ... September 03, 2020 , ... ... with memory impairment, has announced the Best Memory Care Facilities in Louisville, KY. ... facility features and amenities. , According to the Alzheimer’s Association , ...
(Date:9/1/2020)... Calif. (PRWEB) , ... September 01, 2020 , ... ... a new practice in Glendale. While the office will be the ... as breast augmentation, tummy tucks, buttock augmentation (Brazilian butt lift), as well as ...
(Date:9/1/2020)... ... , ... As fall and winter swiftly approach and many businesses cut costs ... this time to expand and grow into a full-fledged natural health clinic over the ... be relaunching its brand new website, expanding its services menu and has recruited top-tier ...
(Date:8/31/2020)... ... 2020 , ... The Lymphoma Research Foundation (LRF) ... and serving the lymphoma community through a comprehensive series of education programs, outreach ... Awareness Month (BCAM) and its international Light it Red for Lymphoma ...
Breaking Medicine News(10 mins):
(Date:9/3/2020)... ... September 03, 2020 , ... Using Analysis of Variance ... Thursday, Sept. 17, 2020, 1:30 p.m.-3:00 p.m. EDT, https://www.fdanews.com/anova , How much ... , While one can’t become one in 90 minutes, one can master a ...
(Date:9/2/2020)... ... September 02, 2020 , ... U.S. Dermatology Partners is ... Dr. Lee will work at Bethesda Dermatopathology Lab. , Jonathan Lee, MD ... University of California, Berkley. He went on to receive his M.D. with Honors from ...
(Date:9/1/2020)... ... 01, 2020 , ... While coronavirus cases continue to increase across the country, ... organizations remain closed. Because about 80% of blood donations are made at drives hosted ... and blood drive hosts to ensure blood products are readily available for patients. ...
Breaking Medicine Technology:
Cached News: